search
Back to results

Prophylactic Closed Incision Negative Pressure Wound Therapy on Abdominal Wounds - Clinical and Economic Perspectives (ProNounCE)

Primary Purpose

Wound Infection, Surgical Site Infection, Surgical Wound

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Wound dressings: Conservative dressings
Wound dressings: Prevena dressings
Wound dressings: ciVAC dressings
Sponsored by
Imperial College London
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Wound Infection focused on measuring Surgical Site infections, Negative Pressure Wound Therapy, Contaminated abdominal wounds, Closed incision abdominal wound, Prophylactic therapy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Emergency, trauma or elective contaminated abdominal operations within general surgery and/or colorectal surgery
  • Abdominal wounds closed at time of operation and expected to heal by primary intention
  • Patients who have the capacity to consent
  • To include complex abdominal wounds with existing infection where wounds have been closed and expected to heal by primary intention
  • To including graft or flap sites as part of general surgical procedure
  • Patients who are able to complete questionnaires post operatively, either alone or with assistance

Exclusion Criteria:

  • Wounds where an appropriate seal cannot be obtained
  • Wounds left open and expected to heal by secondary intention
  • Patients known to have allergy or sensitivity to dressings being used
  • Patients who lack the capacity to consent

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Active Comparator

    Active Comparator

    Active Comparator

    Arm Label

    Conservative dressings

    Prevena dressing

    ciVAC dressing

    Arm Description

    Use of simple dressings on wound post operatively - to be placed at end of operation

    Use of Prevena(KCI) dressing on wound post operatively - to be placed at end of operation

    Use of closed incision VAC (vacuum assisted closure) dressing on wound post operatively - to be placed at end of operation

    Outcomes

    Primary Outcome Measures

    Surgical Site Infection
    The occurrence of surgical site infections at the post-operative wound and timeframe of occurrence

    Secondary Outcome Measures

    Wound assessments - clinical assessment of presence of wound complication and healing
    Independent blind assessment of wounds at day 7 post operatively, on discharge and at outpatient follow up, via wound photographs taken, and correlation with assessment by clinical team
    Length of stay
    Length of stay post-operatively
    Number of additional interventions received by participants due to development of a Surgical Site Infection
    Need for intervention or treatment for surgical site infection (antibiotics, opening up of wound at bedside, operative or radiological intervention)
    Microscopy, culture and sensitivity results from swabs of any Surgical Site Infections
    Culture results if SSI post-operative (including sensitivities)
    Post operative complications - other
    Occurrence of other post-operative complications
    Number of adverse reactions to treatments for Surgical Site Infections
    Adverse reactions to antibiotics given or to dressings use
    Wound dressings - use of
    Time to discontinuation of dressings, type and number of dressings used
    Ninety day mortality rate
    Mortality within 90 days
    Ninety day readmission rate
    Rate of readmission within 90 days
    Cause of death
    Cause of death for any mortalities within 90 days
    Quality of life measures: EuroQol 5 Dimensions 5 Levels (EQ5D5L) questionnaire
    Generic quality of life outcome measures using EQ5D5L questionnaire assessed at day 7 post operatively, on discharge and at outpatient follow up; individualised questions, no formal scale
    Quality of life measures: Wound Quality of Life questionnaires
    Wound specific quality of life outcome measures using Wound Quality of Life questionnaire assessed at day 7 post operatively, on discharge and at outpatient follow up; scales - not at all/a little/moderately/quite a lot/very much
    Quality of life and economic measures: Economic assessment questionnaire
    Assessment of economic impact of wound using single Economic questionnaire to be assessed at day 40; individualised questions that will be assessed, no formal scale
    Long term follow up - Hernia occurrence
    Development of incisional hernia

    Full Information

    First Posted
    September 20, 2019
    Last Updated
    September 26, 2023
    Sponsor
    Imperial College London
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04110353
    Brief Title
    Prophylactic Closed Incision Negative Pressure Wound Therapy on Abdominal Wounds - Clinical and Economic Perspectives
    Acronym
    ProNounCE
    Official Title
    Prophylactic Closed Incision Negative Pressure Wound Therapy on Abdominal Wounds - Clinical and Economic Perspectives: A Multi-centre Randomised Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2023
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    Lack of funding
    Study Start Date
    June 2020 (Anticipated)
    Primary Completion Date
    June 2021 (Anticipated)
    Study Completion Date
    June 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Imperial College London

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This study evaluates whether specialist negative pressure dressings reduce the risk of wound infections after operations when compared to conservative dressings, and if one negative pressure dressings works better than another. The study will look at patients who have had an open operation on their bowel and the wound closed at the end of the operation.
    Detailed Description
    Surgical site infections (SSI) can affect up 41% of patients post-operatively. They are associated with significant healthcare and patient costs, and increased patient morbidity and mortality. Specialist post operative dressings with negative pressure wound therapy are available, and the WHO do recommended for use in high risk wounds, taking resources into account. However no further recommendations are available. This study will explore the rate of post-operative wound infections in adult patients undergoing open abdominal surgery on the bowel, and compare the rate of wound infections in these patients in relation to three different dressing types used after their operation. The study aims to determine if any of the dressings used within the study are associated with lower post-operative wound infection rates, and compare the overall costs of using each dressing type, including both direct healthcare costs and societal costs. Finally, it will evaluate participant's quality of life outcomes after open abdominal surgery, specifically relating to their wound.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Wound Infection, Surgical Site Infection, Surgical Wound, Surgical Incision
    Keywords
    Surgical Site infections, Negative Pressure Wound Therapy, Contaminated abdominal wounds, Closed incision abdominal wound, Prophylactic therapy

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Sequential Assignment
    Model Description
    Stepped wedge design with randomisation at the level of the Hospitals not individual patients
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Conservative dressings
    Arm Type
    Active Comparator
    Arm Description
    Use of simple dressings on wound post operatively - to be placed at end of operation
    Arm Title
    Prevena dressing
    Arm Type
    Active Comparator
    Arm Description
    Use of Prevena(KCI) dressing on wound post operatively - to be placed at end of operation
    Arm Title
    ciVAC dressing
    Arm Type
    Active Comparator
    Arm Description
    Use of closed incision VAC (vacuum assisted closure) dressing on wound post operatively - to be placed at end of operation
    Intervention Type
    Other
    Intervention Name(s)
    Wound dressings: Conservative dressings
    Intervention Description
    Conservative dressings to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.
    Intervention Type
    Other
    Intervention Name(s)
    Wound dressings: Prevena dressings
    Intervention Description
    Prevena dressing to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.
    Intervention Type
    Other
    Intervention Name(s)
    Wound dressings: ciVAC dressings
    Intervention Description
    Closed incision VAC dressings to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.
    Primary Outcome Measure Information:
    Title
    Surgical Site Infection
    Description
    The occurrence of surgical site infections at the post-operative wound and timeframe of occurrence
    Time Frame
    Up to day 90
    Secondary Outcome Measure Information:
    Title
    Wound assessments - clinical assessment of presence of wound complication and healing
    Description
    Independent blind assessment of wounds at day 7 post operatively, on discharge and at outpatient follow up, via wound photographs taken, and correlation with assessment by clinical team
    Time Frame
    At day 7 (on removal of dressing), up to day 30 (on discharge), day 40 (at outpatient follow up)
    Title
    Length of stay
    Description
    Length of stay post-operatively
    Time Frame
    Up to 90 days
    Title
    Number of additional interventions received by participants due to development of a Surgical Site Infection
    Description
    Need for intervention or treatment for surgical site infection (antibiotics, opening up of wound at bedside, operative or radiological intervention)
    Time Frame
    Within 30 days
    Title
    Microscopy, culture and sensitivity results from swabs of any Surgical Site Infections
    Description
    Culture results if SSI post-operative (including sensitivities)
    Time Frame
    Within 30 days
    Title
    Post operative complications - other
    Description
    Occurrence of other post-operative complications
    Time Frame
    Within 30 days
    Title
    Number of adverse reactions to treatments for Surgical Site Infections
    Description
    Adverse reactions to antibiotics given or to dressings use
    Time Frame
    Within 30 days
    Title
    Wound dressings - use of
    Description
    Time to discontinuation of dressings, type and number of dressings used
    Time Frame
    Up to day 30-40
    Title
    Ninety day mortality rate
    Description
    Mortality within 90 days
    Time Frame
    Up to day 90
    Title
    Ninety day readmission rate
    Description
    Rate of readmission within 90 days
    Time Frame
    Up to day 90
    Title
    Cause of death
    Description
    Cause of death for any mortalities within 90 days
    Time Frame
    Up to day 90
    Title
    Quality of life measures: EuroQol 5 Dimensions 5 Levels (EQ5D5L) questionnaire
    Description
    Generic quality of life outcome measures using EQ5D5L questionnaire assessed at day 7 post operatively, on discharge and at outpatient follow up; individualised questions, no formal scale
    Time Frame
    At day 7 (on removal of dressing), up to day 30 (on discharge), day 40 (at outpatient follow up)
    Title
    Quality of life measures: Wound Quality of Life questionnaires
    Description
    Wound specific quality of life outcome measures using Wound Quality of Life questionnaire assessed at day 7 post operatively, on discharge and at outpatient follow up; scales - not at all/a little/moderately/quite a lot/very much
    Time Frame
    At day 7 (on removal of dressing), up to day 30 (on discharge), day 40 (at outpatient follow up)
    Title
    Quality of life and economic measures: Economic assessment questionnaire
    Description
    Assessment of economic impact of wound using single Economic questionnaire to be assessed at day 40; individualised questions that will be assessed, no formal scale
    Time Frame
    At day 40
    Title
    Long term follow up - Hernia occurrence
    Description
    Development of incisional hernia
    Time Frame
    At 1, 3 and 5 years

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Emergency, trauma or elective contaminated abdominal operations within general surgery and/or colorectal surgery Abdominal wounds closed at time of operation and expected to heal by primary intention Patients who have the capacity to consent To include complex abdominal wounds with existing infection where wounds have been closed and expected to heal by primary intention To including graft or flap sites as part of general surgical procedure Patients who are able to complete questionnaires post operatively, either alone or with assistance Exclusion Criteria: Wounds where an appropriate seal cannot be obtained Wounds left open and expected to heal by secondary intention Patients known to have allergy or sensitivity to dressings being used Patients who lack the capacity to consent
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Christopher Peters
    Organizational Affiliation
    Imperial College London
    Official's Role
    Principal Investigator
    First Name & Middle Initial & Last Name & Degree
    Carolynne Vaizey
    Organizational Affiliation
    St Mark's Hospital and Academic Institute
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Prophylactic Closed Incision Negative Pressure Wound Therapy on Abdominal Wounds - Clinical and Economic Perspectives

    We'll reach out to this number within 24 hrs